Pharmaceutical water—whether Purified Water (PW) or Water for Injection (WFI)—remains one of the most heavily scrutinized critical utilities during regulatory inspections.
With ongoing harmonization across USP <1231>, Ph. Eur., and IP, reviewing analytical data for water requires precision beyond basic specification checks:
🔹 TOC Alignment (Ph. Eur. 2.2.44):
The shift to explicit Method A specifications (0.50\text{ mg/L}) and the adoption of Method B for Sterilized Water for Injection (SWFI) make legacy wet-chemistry oxidizable substance testing obsolete.
🔹 Membrane-Based WFI Generation:
Non-distillation generation (RO + EDI + UF) is firmly established, shifting regulatory scrutiny heavily toward real-time online TOC and conductivity monitoring, automated divert valves, and robust microbial biofilm controls.
🔹 Data Integrity & In-Line Review:
Auditors are placing greater emphasis on audit trails for online instrumentation. Reviewing water testing records means verifying calibration tolerances against certified reference standards, sensor loop verifications, and alarm logs—not just accepting off-line bench sheets.
📌 Key Takeaway for QC/QA Teams:
Harmonized chemical criteria simplify global dossier alignments, but operational data integrity on continuous analyzers is where compliance is won or lost.
How is your facility managing the transition toward in-line real-time release testing for critical water loops?
#PharmaceuticalWater #QualityControl #QualityAssurance #USP #PhEur #Pharmacopoeia #DataIntegrity #AnalyticalChemistry #WaterForInjection #PharmaCompliance #LifeSciences
